Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dr.Lac KYOU (닥터락 깨유) is a patented Lactobacillus-based probiotic developed by LuxBiome. It is marketed as a functional food or live biotherapeutic designed to alleviate hangovers and prevent alcohol-induced liver injury. The mechanism of action involves microbiome-mediated metabolism, where the probiotic strains facilitate the breakdown of alcohol and its toxic metabolite, acetaldehyde, within the gastrointestinal tract. This reduction in systemic toxin levels helps mitigate the physiological effects of alcohol consumption. The product is currently approved and available as an oral supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dr.Lac KYOU.